Patents by Inventor Chandru GAJENDRAN

Chandru GAJENDRAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
    Publication number: 20220281815
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Application
    Filed: April 29, 2022
    Publication date: September 8, 2022
    Inventors: Sridharan RAJAGOPAL, Mahanandeesha S. HALLUR, Purushottam DEWANG, Kannan MURUGAN, Durga Prasanna KUMAR C.H., Pravin IYER, Chandrika MULAKALA, Dhanalakshmi SIVANANDHAN, Sreekala NAIR, Mohd ZAINUDDIN, Subramanyam Janardhan TANTRY, Chandru GAJENDRAN, Sriram RAJAGOPAL
  • Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
    Patent number: 11352322
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: June 7, 2022
    Assignee: Jubilant Epicore LLC
    Inventors: Sridharan Rajagopal, Mahanandeesha S. Hallur, Purushottam Dewang, Kannan Murugan, Durga Prasanna Kumar C. H., Pravin Iyer, Chandrika Mulakala, Dhanalakshmi Sivanandhan, Sreekala Nair, Mohd Zainuddin, Subramanyam Janardhan Tantry, Chandru Gajendran, Sriram Rajagopal
  • CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
    Publication number: 20200308110
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Application
    Filed: May 8, 2017
    Publication date: October 1, 2020
    Inventors: Sridharan RAJAGOPAL, Mahanandeesha S. HALLUR, Purushottam DEWANG, Kannan MURUGAN, Durga Prasanna KUMAR C.H., Pravin IYER, Chandrika MULAKALA, Dhanalakshmi SIVANANDHAN, Sreekala NAIR, Mohd ZAINUDDIN, Subramanyam Janardhan TANTRY, Chandru GAJENDRAN, Sriram RAJAGOPAL